Gain Therapeutics Cash Flow Statement (2020-2025) | GANX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M3.07M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M17.94M
Depreciation and Depletion (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M
Share-based Compensation (Quarter) 0.00M0.08M0.11M0.19M0.25M-0.02M0.31M0.31M0.36M0.56M0.57M1.32M0.82M0.56M0.19M1.48M0.36M0.36M0.42M0.52M0.46M0.40M
Gains from Sales and Divestitures (Quarter) 0.07M0.16M0.17M0.03M0.04M0.06M0.06M0.06M0.10M0.10M
Gains from Investment Securities (Quarter) 0.03M0.01M0.52M0.09M-0.40M0.09M0.01M1.92M-0.06M0.12M2.60M0.00M0.14M3.53M0.03M0.79M-0.39M0.02M0.05M4.13M0.05M
Non-cash Items (Quarter) 11.541.31M0.13M0.16M2.10M2.61M0.03M1.52M1.91M
Change in Working Capital (Quarter) 0.17M-0.12M-0.03M-0.27M0.47M0.19M-1.72M1.38M
Cash from Operations (Quarter) -0.75M-0.42M-0.76M-1.31M-2.81M-3.22M-2.19M-4.15M-2.45M-5.05M-3.29M-3.90M-4.22M-5.02M-3.97M-5.66M-3.59M-5.76M-6.08M-3.45M-3.82M-5.10M-4.93M-4.62M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.03M
Change in Working Capital
Change in Receivables (Quarter) -0.06M0.16M-0.11M0.01M0.51M-0.17M-0.33M-0.02M
Change in Account Payables (Quarter) 0.08M1.54M
Change in Accured Expenses (Quarter) -0.18M0.15M0.16M0.05M0.00M0.09M1.16M-0.59M1.74M-0.51M0.30M-0.82M1.06M-0.68M-0.05M-0.33M0.70M1.48M-1.85M-0.06M1.11M0.15M-0.95M-0.79M
Change in Taxes (Quarter) -0.00M0.00M
Investing Activities
Capital Expenditures (Quarter) 0.00M-38.000.00M0.01M0.03M0.02M0.03M0.01M0.01M0.04M0.06M0.01M0.01M0.00M650.0019.001.00945.00
Change in Acquisitions & Divestments (Quarter) 2.07M4.07M3.05M1.93M3.14M3.02M2.02M-0.04M
Cash from Investing Activities (Quarter) -0.00M38.00-0.00M-0.01M-0.03M-0.02M-0.03M-0.01M-0.01M-14.89M-0.01M0.13M2.11M3.05M1.93M3.14M3.02M2.00M-1.00-0.04M
Financing Activities
Other financing activities (Quarter) 0.47M0.64M0.21M0.15M1.43M0.35M0.42M0.53M0.46M-1.02M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.28M0.42M0.03M
Short-Term Debt repayments (Quarter) 0.04M-0.00M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.03M
Change in Capital Stock
Shares Issued (Quarter) 42.63M0.77M2.22M0.16M0.75M0.10M0.01M-0.06M2.49M2.67M0.04M3.18M
Preferred Shares Issued (Quarter) 1.11M-0.01M9.90M
Misc.
Cash from Financing Activities (Quarter) 1.39M-0.01M9.55M-0.44M41.99M-0.21M-0.01M-0.04M0.00M-0.02M-0.02M0.75M2.20M0.13M9.56M-0.15M10.04M0.81M2.31M2.40M2.47M7.03M16.55M
Exchange Rate Effect (Quarter) -0.00M0.00M-0.02M-0.01M-0.02M0.02M0.03M0.06M-0.05M-0.09M-0.11M0.23M0.04M0.11M-0.14M0.48M-0.44M0.01M0.38M-0.48M0.11M0.26M0.01M0.10M
Change in Cash (Quarter) 0.63M-0.43M8.77M-1.77M39.13M-3.43M-2.19M-4.10M-2.54M-20.03M-3.43M-3.57M-1.32M0.33M-2.05M7.53M-1.16M6.30M-4.88M-1.67M-1.31M-2.37M2.11M12.03M
Free Cash Flow (Quarter) -0.76M-0.42M-0.76M-1.32M-2.84M-3.24M-2.22M-4.16M-2.46M-5.10M-3.35M-3.91M-4.23M-5.03M-3.97M-5.66M-3.59M-5.76M-6.08M-3.46M-3.82M-5.10M-4.93M-4.62M
Net Cash Flow (Quarter) 0.63M-0.43M8.79M-1.76M39.15M-3.45M-2.22M-4.17M-2.49M-19.94M-3.32M-3.79M-1.36M0.22M-1.90M7.04M-0.71M6.28M-5.27M-1.19M-1.42M-2.63M2.11M11.93M